Emicizumab assays evaluations with four different reagents in severe haemophilia A patients: Concentration from baseline to maintenance therapy

Haemophilia. 2023 Jan;29(1):374-376. doi: 10.1111/hae.14703. Epub 2022 Nov 29.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Bispecific* / pharmacology
  • Antibodies, Bispecific* / therapeutic use
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Factor VIII / therapeutic use
  • Hemophilia A* / drug therapy
  • Humans

Substances

  • emicizumab
  • Antibodies, Bispecific
  • Antibodies, Monoclonal, Humanized
  • Factor VIII